MedPath

Glofil-125

Glofil-125

Approved
Approval ID

7f250086-2837-484b-9674-e09856b34cb0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 9, 2019

Manufacturers
FDA

Iso-Tex Diagnostics, Inc.

DUNS: 181202995

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Iothalamate I-125 injection

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50914-7729
Application NumberNDA017279
Product Classification
M
Marketing Category
C73594
G
Generic Name
Sodium Iothalamate I-125 injection
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 23, 2018
FDA Product Classification

INGREDIENTS (4)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
IOTHALAMATE SODIUM I-125Active
Quantity: 0.275 mCi in 1 mL
Code: 31J5U3Q9ZN
Classification: ACTIB
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
SODIUM BICARBONATEInactive
Code: 8MDF5V39QO
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Glofil-125 - FDA Drug Approval Details